• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Anaplastic Plasmacytoma

Anaplastic Plasmacytoma - 139 Studies Found

Active, not recruiting : Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant
:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Adult Acute Lymphoblastic Leukemia in Remissi
    : 2012-04-26
    :
    • Biological: tetanus-CMV fusion peptide vaccine

Completed : UARK 2005-05, Coagulation-Related Effects of Velcade Treatment in Patients With Relapsed or Refractory Multiple Myeloma
: MULTIPLE MYELOMA
: 2007-12-07
: Drug: Velcade Except for the two PCR-based genotyping assa
Completed : Comparable Investigation of One Fraction Radiotherapy and Multifraction Radiotherapy in Patients With Multiple Myeloma.
: Multiple Myeloma and Malignant Plasma Cell Neoplasms
: 2013-12-19
: Radiation: External Beam radiotherapy External Beam radiotherapy
Active, not recruiting : Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
: Multiple Myeloma and Plasma Cell Neoplasm
: 2009-07-17
:
  • Drug: busulfan IV busulfan 0.8

Completed : Treated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple Myeloma
: Multiple Myeloma and Plasma Cell Neoplasm
: 2009-07-11
:
  • Biological: anti-CD3 x anti-CD20 bispecific antibody-armed activated T cells

Completed : Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide or Lenalidomide
: Multiple Myeloma and Plasma Cell Neoplasm
: 2009-05-09
:
  • Genetic: gene expression analysis
  • Genetic:

Completed : Study of DNA Samples From Patients With Multiple Myeloma
: Multiple Myeloma and Plasma Cell Neoplasm
: 2009-05-09
: Genetic: polymorphism analysis
Active, not recruiting : Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
:
  • Multiple Myeloma
  • Plasma Cell Neoplasm

: 2008-11-13
:
  • Drug: Group A=30-60 CrCl (mL/min)

Active, not recruiting : Vorinostat and Lenalidomide After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
:
  • Multiple Myeloma
  • Plasma Cell Neoplasm

: 2008-08-06
:
  • Drug: lenalidomide combined wi

Completed : Samarium Sm 153 Lexidronam Pentasodium and High-Dose Melphalan in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant
: Multiple Myeloma and Plasma Cell Neoplasm
: 2008-01-15
:
  • Biological: sargramostim
  • Drug: melphalan

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.